Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature
- V. Bergk, W. Haefeli, C. Gasse, H. Brenner, M. Martin-Facklam
- Medicine
- European Journal of Clinical Pharmacology
- 28 June 2005
ObjectiveTo compare comprehensiveness and accuracy of drug interaction information in the German summary of product characteristics (SPC) with current evidence from the literature and to evaluate the… Expand
Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.
- M. Martin-Facklam, J. Burhenne, +4 authors W. Haefeli
- Medicine
- British journal of clinical pharmacology
- 1 June 2002
AIMS
Bioavailability of orally administered drugs depends on several factors including active excretion, e.g. by P-glycoprotein (PGP), and presystemic metabolism, e.g. by cytochrome P450 3A (CYP3A),… Expand
Drug dosage in patients with renal failure optimized by immediate concurrent feedback
- Ariane D. Falconnier, W. Haefeli, R. Schoenenberger, C. Surber, M. Martin-Facklam
- Medicine
- Journal of General Internal Medicine
- 1 June 2001
AbstractOBJECTIVE: To examine the impact of immediate concurrent feedback on dose adjustment in patients with renal failure.
DESIGN: Prospective 12-month study in patients with various degrees of… Expand
Case Report: A Drug Database Model as a Central Element for Computer-Supported Dose Adjustment within a CPOE System
- P. Martin, W. Haefeli, M. Martin-Facklam
- Medicine, Computer Science
- J. Am. Medical Informatics Assoc.
- 1 September 2004
TLDR
Quality markers of drug information on the Internet: an evaluation of sites about St. John's wort.
- M. Martin-Facklam, M. Kostrzewa, F. Schubert, C. Gasse, W. Haefeli
- Medicine
- The American journal of medicine
- 15 December 2002
PURPOSE
We aimed to evaluate websites about St. John's wort for the quality of their content, including accuracy as reflected by statement of correct indication and mentioning of interacting drugs,… Expand
Oral contraception does not alter single dose saquinavir pharmacokinetics in women.
- M. Fröhlich, J. Burhenne, +5 authors W. Haefeli
- Medicine
- British journal of clinical pharmacology
- 1 March 2004
AIMS
Women experience more adverse drug reactions (ADR) to antiretroviral therapy than men. This may be attributed to higher plasma concentrations of protease inhibitors due to pharmacokinetic… Expand
Undeclared exposure to St. John's Wort in hospitalized patients.
- M. Martin-Facklam, K. Rieger, K. Riedel, J. Burhenne, I. Walter-Sack, W. Haefeli
- Medicine
- British journal of clinical pharmacology
- 1 October 2004
AIM
The herbal medicine St. John's Wort (SJW) causes substantial decreases in the plasma concentrations of a range of co-administered drugs. Therefore, we evaluated the extent of systemic exposure to… Expand
Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?
- M. Martin-Facklam, J. Rengelshausen, +5 authors W. Haefeli
- Medicine
- European Journal of Clinical Pharmacology
- 2004
ObjectiveAn important information source for pharmacotherapy in populations at risk is drug labelling. We compared the recommendations for patients with renal insufficiency included in German drug… Expand
Quality of drug information on the World Wide Web and strategies to improve pages with poor information quality. An intervention study on pages about sildenafil.
- M. Martin-Facklam, M. Kostrzewa, P. Martin, W. Haefeli
- Medicine
- British journal of clinical pharmacology
- 14 November 2003
AIMS
The generally poor quality of health information on the world wide web (WWW) has caused preventable adverse outcomes. Quality management of information on the internet is therefore critical… Expand
High prevalence of unknown co-medication in hospitalised patients
- K. Rieger, A. Scholer, +5 authors M. Martin-Facklam
- Medicine
- European Journal of Clinical Pharmacology
- 10 June 2004
ObjectiveCo-medication unknown to the treating physician, including self-medication, may compromise drug safety by increasing the risk of duplicate therapy, drug interactions and adverse drug… Expand